Hong Kong-listed company Huajian Medical has suspended the acquisition of cryptocurrency

According to the announcement from the Hong Kong Stock Exchange, Hong Kong-listed company Huajian Medical disclosed a potential major acquisition plan to acquire cryptocurrency for no more than 3 billion yuan, announced in mid-August, and planned to submit it for shareholder approval. However, it has not sent a circular to shareholders as scheduled, and there has been no progress after two and a half months.

Huajian Medical stated that it requires additional time to obtain shareholder authorization and has temporarily suspended the major acquisition. In the future, when it continues to purchase ETH (Ethereum) in the market, it will disclose this in accordance with the listing rules of the Hong Kong Stock Exchange, particularly Chapter 14, which pertains to the disclosure of transactions. Huajian Medical added that its subsequent plan is to build an AI algorithm platform to improve recognition rates and intends to integrate its distribution network, ecosystem, and RWA platform to enhance the accuracy of the underlying asset valuation model and the efficiency and transparency of the securitization process.